Educational companion dossier · Fact, interpretation, lived experience, clinical education, fiction, and mechanics are labeled separately. Scope & safety
PsychologicalWar.orgPeople before labels.

FICTIONAL PLANNING REGISTER

World-event scenarios, 2027–2036

Explore 3,000 annualized scenario rows from the supplied workbook. Every row is fictional, every numerical estimate is source-authored and non-calibrated, and every consequence path is illustrative rather than predictive.

Browse scenarios Inspect evidence lineage Inspect assumptions Return to the 1999–2026 record
FICTIONAL SCENARIO — NOT HISTORICAL, NOT A FORECAST The provenance of this block requires editorial review.
Confidence
Source-bounded scenario register
Sources
1
Independent corroboration
0
Date range
2027–2036
Review
Exact workbook bytes preserved; scenario assumptions, baselines, and estimates require claim-specific review
How to read this register

FICTIONAL SCENARIO — NOT HISTORICAL, NOT A FORECAST. Probability fields are source-authored analytical estimates, not calibrated forecasts and not additive. Consequence scores are comparison aids, not expected casualties, financial losses, or site rankings. Coordinates are broad centroids, not target locations.

Scenario rows
3,000
Scenario tracks
300
Years
2027–2036
Rows per year
300
Baseline source URLs
19

FICTIONAL SCENARIO — NOT HISTORICAL, NOT A FORECAST

2035-S121Track W003Q4 2035

Iran nuclear threshold or safeguards crisis — 2035 outlook

Nuclear proliferation / safeguards crisis · Tehran and Persian Gulf region

Nuclear / WMD · Moderate 16.5% source estimate · magnitude 5/5 · priority 5/5

FICTIONAL SCENARIO — NOT HISTORICAL, NOT A FORECAST

2035-S283Track CH007Any quarter 2035

Large earthquake strikes a major urban fault zone — 2035 outlook

Earthquake / urban catastrophe · Istanbul or a comparable high-exposure metropolitan fault zone

Climate / health · Low 8.1% source estimate · magnitude 5/5 · priority 3/5
FICTIONAL SCENARIO — NOT HISTORICAL, NOT A FORECAST The provenance of this block requires editorial review.
Confidence
Moderate
Sources
1
Independent corroboration
0
Date range
Q1 2035
Review
Scenario premise, probability, and consequences require claim-specific review

FICTIONAL SCENARIO — NOT HISTORICAL, NOT A FORECAST

SOURCE ROW 2418 · TRACK TS005

AI-designed therapy achieves a major medical breakthrough — 2035 outlook

In 2035, the modeled trigger or precursor is: an AI-guided discovery and trial program produces a clearly superior therapy for a high-burden disease. The breakthrough validates new methods for target identification, molecule design, trial selection or personalized treatment. It changes investment across pharmaceuticals and raises questions about data access and affordability. By the mid-2030s, highly capable autonomous systems and strategic space infrastructure could create new single points of failure and coercive leverage. The annual probability is an approximate analytical estimate of 39.1% (Elevated), with consequence magnitude 5/5. This row is a plausible, overlapping scenario—not a prediction.

Stable scenario ID
2035-S017
Track ID
TS005
Illustrative window
Q1 2035
Category
Technology / space
Impact scope
Global
Outcome direction
Beneficial
Broad geography
Boston, Basel, London, Shanghai and major biomedical hubs · Global research ecosystem
Coordinate precision
Representative biomedical-research hub coordinate
Confidence label
Moderate
Operational use
Not allowed by this educational transformation

SOURCE-AUTHORED ANALYTICAL ESTIMATE — NOT CALIBRATED OR ADDITIVE

Annual estimate
39.1%
Band
Elevated
Magnitude
5/5
Weighted score
39.1/100
Planning priority
5/5

Workbook formula: probability ÷ 100 × magnitude × 20. It is a comparison aid only. Scenario probabilities overlap and must not be summed.

Scenario premise

an AI-guided discovery and trial program produces a clearly superior therapy for a high-burden disease.

Named actor classes

biotechnology and pharmaceutical firms; universities; regulators; hospitals; patients; insurers

Warning indicators

replicated clinical endpoints; transparent validation; multiple independent platform successes; scalable manufacturing; payer acceptance

Indicators are planning prompts, not proof that the scenario is occurring and not a monitoring or targeting instruction.

Key uncertainties

generalizability beyond one therapy, hidden data biases, long-term safety and whether lower research cost translates into affordable treatment

ILLUSTRATIVE CONSEQUENCE PATH — NOT A PREDICTION

Conditional consequence sequence

  1. 0–30 days

    If this scenario occurs in 2035: Regulators accelerate review and competitors redirect research portfolios. Demand rises for relevant clinical data, compute and specialized manufacturing.

  2. 1–3 years

    During 2036–2038: Similar platforms generate follow-on therapies and trial design becomes more adaptive. Health systems negotiate pricing and evidence requirements.

  3. 4–10 years

    Across 2039–2045: Drug-development timelines and failure rates decline for some disease classes, improving health and productivity. Benefits remain uneven unless manufacturing and financing broaden access.

Baseline source — not endorsement of this scenario or estimate

OECD AI Policy Observatory; used for AI incidents, governance and frontier-model risk framing.

Open the workbook’s baseline source

BASELINE START POINT ONLY

Track evidence review remains open

Review ID
SER-TS005
Review state
READY FOR CLAIM-SPECIFIC REVIEW
Premise verification
NOT REVIEWED
Probability calibration
NOT PERFORMED
Independent origins
0
Assignment state
OPEN_UNASSIGNED

A source relationship records where review can begin. It does not verify this fictional premise, calibrate the annual estimates, validate the consequence path, or grant operational authority.

Open the claim-specific review docket

ASSUMPTION IS NOT FACT

Track assumptions and retirement remain open

Assumption ID
SAR-TS005
Premise review
NOT REVIEWED
Indicator review
NOT REVIEWED
Retirement state
NOT EVALUATED

The sidecar exposes dependencies, disconfirming questions, alternative explanations, false-alarm risks, consequence interruptions, and retirement triggers. It does not predict, monitor, or retire this track.

Open the assumption review docket
Safety and use boundary

Strategic technology and space-governance scenario only. It omits exploit methods, model-evasion techniques, satellite targeting data and other operational details that could facilitate harm. This site adds no tactical target data, exploit steps, evasion methods, weapon construction, casualty optimization, or authorization for real-world action.

SOURCE-AUTHORED ANALYTICAL ESTIMATE — NOT CALIBRATED OR ADDITIVE

Ten-year track: TS005

The workbook annualizes the same scenario family once per year so readers can compare how its assumptions and numerical estimates change. This is not a time-series forecast.

Source-authored annualized rows for track TS005
YearScenario IDProbabilityBandMagnitudeWeighted scorePriorityConfidence
2027 2027-S043 23.3% Moderate 5/5 23.3 5/5 Moderate
2028 2028-S028 26.6% Moderate 5/5 26.6 5/5 Moderate
2029 2029-S024 28.0% Moderate 5/5 28.0 5/5 Moderate
2030 2030-S019 30.1% Elevated 5/5 30.1 5/5 Moderate
2031 2031-S018 31.5% Elevated 5/5 31.5 5/5 Moderate
2032 2032-S017 34.1% Elevated 5/5 34.1 5/5 Moderate
2033 2033-S020 33.4% Elevated 5/5 33.4 5/5 Moderate
2034 2034-S022 34.4% Elevated 5/5 34.4 5/5 Moderate
2035 2035-S017 39.1% Elevated 5/5 39.1 5/5 Moderate
2036 2036-S019 38.5% Elevated 5/5 38.5 5/5 Moderate

READ THE DATA

Scenario-register literacy

Learn why repeated annual rows are intentional, why probability bands do not add, and why warning indicators are not event confirmation.

Open the guide

CHECK THE BOUNDARY

History, scenarios, and projections

Review the rules that prevent the 1999–2026 historical ledger from silently becoming future fact.

Open the boundary guide

RETURN TO HISTORY

1999–2026 event explorer

Browse the unchanged historical and contemporary source records before crossing into fictional material.

Open historical replay